NCT03330327

Molar Potency Study of HM12470 in Healthy Subjects

An Open Label, Fixed-Sequence, Glucose Clamp Study to Compare Molar Potency of HM12470 and Regular Human Insulin in Healthy Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 56 (actual)
• Sponsor: Hanmi Pharmaceutical Company Limited · Industry
• Sex: All
• Age: 18 Years – 60 Years
• Healthy volunteers: Accepted

Summary

This is a phase 1 study to assess and compare molar potency of HM12470 and regular human insulin in healthy subjects.

Conditions

• Healthy Subjects

Interventions

Type	Name	Description
BIOLOGICAL	HM12470	HM12470 is a long-acting insulin analogue

Timeline

• Start date: 2015-03-30
• Primary completion: 2017-08-17
• Completion: 2017-08-17
• First posted: 2017-11-06
• Last updated: 2017-11-06

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study